KIMSKrishna Institute of Medical Sciences Limited
Convert to ideaHealthcare · Healthcare Facilities
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.4 this quarter.
Momentum from moving averages, Supertrend and RSI.
5 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
5 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹1344 Cr | ₹75 Cr | 10.38% | 5.55% | ₹1.79 | 2.6x |
| Q1 FY2027 | ₹1180 Cr | ₹37 Cr | 10.39% | 3.17% | ₹1.04 | 1.7x |
| Q4 FY2026 | ₹1075 Cr | ₹33 Cr | 11.31% | 3.08% | ₹1.06 | 1.8x |
| Q3 FY2026 | ₹998 Cr | ₹52 Cr | 12.05% | 5.20% | ₹1.33 | 2.2x |
| Q2 FY2026 | ₹961 Cr | ₹72 Cr | 14.35% | 7.49% | ₹1.67 | 3.2x |
| Q1 FY2026 | ₹872 Cr | ₹85 Cr | 15.97% | 9.75% | ₹1.96 | 4.5x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Facilities
Compare with peers →Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interventional radiology; paediatrics and pediatric sub specialities, and neonatology; maxillo-facial surgery; OT and day care anaesthesia and pain medicine; and pathology, microbiology, and biochemistry. Additionally, the company offers molecular biology and clinical hematology; internal medicine, general surgery, and diabetology and endocrinology; and ICU, CTICU, SICU, NICU, PICU, neuro and ECMO ICU, and post transplant ICU services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.